CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 104 enrolled
Drug / intervention
No Interventiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01636765
NCT01636765N/ACompleted
CompareCT.gov

Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale

Allergan·observational·Posted Jul 10, 2012·Updated Nov 18, 2019

In Brief

An observational study evaluating No Intervention for Erythema and Rosacea. Completed, enrolled 104 participants across 1 site.

Detailed Summary

This is a study to evaluate inter- and intra-rater reliability of the Clinician Erythema Assessment Scale. There is no treatment (intervention) associated with this study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsErythema, Rosacea
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 10, 2012
Enrollment StartMay 1, 2012
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.0 years ago

Interventions

No Interventiondrug

No intervention.